Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

EMR vs AME

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EMR
Emerson Electric Co.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$79.02B
5Y Perf.+131.2%
AME
AMETEK, Inc.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$53.72B
5Y Perf.+155.7%

EMR vs AME — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EMR logoEMR
AME logoAME
IndustryIndustrial - MachineryIndustrial - Machinery
Market Cap$79.02B$53.72B
Revenue (TTM)$18.32B$7.60B
Net Income (TTM)$2.44B$1.53B
Gross Margin52.7%36.6%
Operating Margin19.8%26.2%
Forward P/E21.7x29.1x
Total Debt$13.76B$2.28B
Cash & Equiv.$1.54B$458M

EMR vs AMELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EMR
AME
StockMay 20May 26Return
Emerson Electric Co. (EMR)100231.2+131.2%
AMETEK, Inc. (AME)100255.7+155.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: EMR vs AME

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AME leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Emerson Electric Co. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
EMR
Emerson Electric Co.
The Income Pick

EMR is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 37 yrs, beta 1.52, yield 1.5%
  • Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
  • Lower P/E (21.7x vs 29.1x)
Best for: income & stability and growth exposure
AME
AMETEK, Inc.
The Long-Run Compounder

AME carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 423.4% 10Y total return vs EMR's 206.6%
  • Lower volatility, beta 0.93, Low D/E 21.5%, current ratio 1.06x
  • PEG 2.60 vs EMR's 4.81
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthAME logoAME6.6% revenue growth vs EMR's 3.0%
ValueEMR logoEMRLower P/E (21.7x vs 29.1x)
Quality / MarginsAME logoAME20.1% margin vs EMR's 13.3%
Stability / SafetyAME logoAMEBeta 0.93 vs EMR's 1.52, lower leverage
DividendsEMR logoEMR1.5% yield, 37-year raise streak, vs AME's 0.5%
Momentum (1Y)AME logoAME+38.9% vs EMR's +30.4%
Efficiency (ROA)AME logoAME9.6% ROA vs EMR's 5.8%, ROIC 12.1% vs 8.2%

EMR vs AME — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EMREmerson Electric Co.
FY 2025
Intelligent Devices
68.5%$12.4B
Software and Control
31.5%$5.7B
AMEAMETEK, Inc.
FY 2025
Electronic Instruments Group
66.5%$4.9B
Electromechanical Group
33.5%$2.5B

EMR vs AME — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAMELAGGINGEMR

Income & Cash Flow (Last 12 Months)

AME leads this category, winning 4 of 6 comparable metrics.

EMR is the larger business by revenue, generating $18.3B annually — 2.4x AME's $7.6B. AME is the more profitable business, keeping 20.1% of every revenue dollar as net income compared to EMR's 13.3%. On growth, AME holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.
RevenueTrailing 12 months$18.3B$7.6B
EBITDAEarnings before interest/tax$4.7B$2.3B
Net IncomeAfter-tax profit$2.4B$1.5B
Free Cash FlowCash after capex$3.1B$1.7B
Gross MarginGross profit ÷ Revenue+52.7%+36.6%
Operating MarginEBIT ÷ Revenue+19.8%+26.2%
Net MarginNet income ÷ Revenue+13.3%+20.1%
FCF MarginFCF ÷ Revenue+17.0%+22.4%
Rev. Growth (YoY)Latest quarter vs prior year+2.9%+11.3%
EPS Growth (YoY)Latest quarter vs prior year+28.2%+14.5%
AME leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

EMR leads this category, winning 6 of 7 comparable metrics.

At 34.9x trailing earnings, EMR trades at a 5% valuation discount to AME's 36.6x P/E. Adjusting for growth (PEG ratio), AME offers better value at 3.28x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.
Market CapShares × price$79.0B$53.7B
Enterprise ValueMkt cap + debt − cash$91.2B$55.5B
Trailing P/EPrice ÷ TTM EPS34.92x36.64x
Forward P/EPrice ÷ next-FY EPS est.21.71x29.08x
PEG RatioP/E ÷ EPS growth rate7.73x3.28x
EV / EBITDAEnterprise value multiple18.07x29.55x
Price / SalesMarket cap ÷ Revenue4.39x7.26x
Price / BookPrice ÷ Book value/share3.94x5.10x
Price / FCFMarket cap ÷ FCF29.63x32.14x
EMR leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

AME leads this category, winning 8 of 8 comparable metrics.

AME delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $12 for EMR. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.
ROE (TTM)Return on equity+12.1%+14.4%
ROA (TTM)Return on assets+5.8%+9.6%
ROICReturn on invested capital+8.2%+12.1%
ROCEReturn on capital employed+10.0%+15.0%
Piotroski ScoreFundamental quality 0–977
Debt / EquityFinancial leverage0.68x0.21x
Net DebtTotal debt minus cash$12.2B$1.8B
Cash & Equiv.Liquid assets$1.5B$458M
Total DebtShort + long-term debt$13.8B$2.3B
Interest CoverageEBIT ÷ Interest expense6.46x23.34x
AME leads this category, winning 8 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

AME leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in AME five years ago would be worth $17,454 today (with dividends reinvested), compared to $15,945 for EMR. Over the past 12 months, AME leads with a +38.9% total return vs EMR's +30.4%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.7% vs AME's 18.0% — a key indicator of consistent wealth creation.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.
YTD ReturnYear-to-date+4.3%+12.3%
1-Year ReturnPast 12 months+30.4%+38.9%
3-Year ReturnCumulative with dividends+75.9%+64.1%
5-Year ReturnCumulative with dividends+59.5%+74.5%
10-Year ReturnCumulative with dividends+206.6%+423.4%
CAGR (3Y)Annualised 3-year return+20.7%+18.0%
AME leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

AME leads this category, winning 2 of 2 comparable metrics.

AME is the less volatile stock with a 0.93 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AME currently trades 96.4% from its 52-week high vs EMR's 85.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.
Beta (5Y)Sensitivity to S&P 5001.52x0.93x
52-Week HighHighest price in past year$165.15$243.18
52-Week LowLowest price in past year$108.37$168.49
% of 52W HighCurrent price vs 52-week peak+85.4%+96.4%
RSI (14)Momentum oscillator 0–10061.363.3
Avg Volume (50D)Average daily shares traded2.8M1.2M
AME leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

EMR leads this category, winning 2 of 2 comparable metrics.

Wall Street rates EMR as "Buy" and AME as "Buy". Consensus price targets imply 14.8% upside for EMR (target: $162) vs 4.9% for AME (target: $246). For income investors, EMR offers the higher dividend yield at 1.49% vs AME's 0.53%.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$161.92$245.91
# AnalystsCovering analysts4129
Dividend YieldAnnual dividend ÷ price+1.5%+0.5%
Dividend StreakConsecutive years of raises3716
Dividend / ShareAnnual DPS$2.10$1.23
Buyback YieldShare repurchases ÷ mkt cap+1.6%+0.8%
EMR leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

AME leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMR leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallAMETEK, Inc. (AME)Leads 4 of 6 categories
Loading custom metrics...

EMR vs AME: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is EMR or AME a better buy right now?

For growth investors, AMETEK, Inc.

(AME) is the stronger pick with 6. 6% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Emerson Electric Co. (EMR) offers the better valuation at 34. 9x trailing P/E (21. 7x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EMR or AME?

On trailing P/E, Emerson Electric Co.

(EMR) is the cheapest at 34. 9x versus AMETEK, Inc. at 36. 6x. On forward P/E, Emerson Electric Co. is actually cheaper at 21. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AMETEK, Inc. wins at 2. 60x versus Emerson Electric Co. 's 4. 81x.

03

Which is the better long-term investment — EMR or AME?

Over the past 5 years, AMETEK, Inc.

(AME) delivered a total return of +74. 5%, compared to +59. 5% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: AME returned +423. 4% versus EMR's +206. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EMR or AME?

By beta (market sensitivity over 5 years), AMETEK, Inc.

(AME) is the lower-risk stock at 0. 93β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 63% more volatile than AME relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — EMR or AME?

By revenue growth (latest reported year), AMETEK, Inc.

(AME) is pulling ahead at 6. 6% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to 7. 9% for AMETEK, Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EMR or AME?

AMETEK, Inc.

(AME) is the more profitable company, earning 20. 0% net margin versus 12. 7% for Emerson Electric Co. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AME leads at 26. 2% versus 19. 6% for EMR. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EMR or AME more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, AMETEK, Inc. (AME) is the more undervalued stock at a PEG of 2. 60x versus Emerson Electric Co. 's 4. 81x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Emerson Electric Co. (EMR) trades at 21. 7x forward P/E versus 29. 1x for AMETEK, Inc. — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 8% to $161. 92.

08

Which pays a better dividend — EMR or AME?

All stocks in this comparison pay dividends.

Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 5% for AMETEK, Inc. (AME).

09

Is EMR or AME better for a retirement portfolio?

For long-horizon retirement investors, AMETEK, Inc.

(AME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 0. 5% yield, +423. 4% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AME: +423. 4%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EMR and AME?

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

EMR

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

AME

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform EMR and AME on the metrics below

Revenue Growth>
%
(EMR: 2.9% · AME: 11.3%)
Net Margin>
%
(EMR: 13.3% · AME: 20.1%)
P/E Ratio<
x
(EMR: 34.9x · AME: 36.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.